APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 36 filers reported holding APPLIED MOLECULAR TRANS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178 | -39.2% | 1,135 | 0.0% | 0.00% | – |
| Q2 2023 | $293 | – | 1,135 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 1,135 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,135 | -56.5% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 2,611 | +54.0% | 0.00% | – |
| Q2 2022 | $5,000 | -96.8% | 1,696 | -91.9% | 0.00% | – |
| Q1 2022 | $158,000 | -34.7% | 20,953 | +21.2% | 0.00% | – |
| Q4 2021 | $242,000 | -40.7% | 17,281 | +9.6% | 0.00% | – |
| Q3 2021 | $408,000 | -41.6% | 15,766 | +3.1% | 0.00% | – |
| Q2 2021 | $699,000 | +37.9% | 15,288 | +32.6% | 0.00% | – |
| Q1 2021 | $507,000 | +166.8% | 11,527 | +86.6% | 0.00% | – |
| Q4 2020 | $190,000 | +32.9% | 6,177 | +33.4% | 0.00% | – |
| Q3 2020 | $143,000 | – | 4,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
| Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
| EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
| STATE STREET CORP | 55,055 | $8,644 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
| Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |